YHYing Hu

Ying Hu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying Hu has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Qun Chen

    Departments of Medicine, Division of Cardiology, Virginia Commonwealth University, Richmond, VA 23298, USA

    3 shared publications
  • Edward J. Lesnefsky

    Departments of Medicine, Division of Cardiology, Virginia Commonwealth University, Richmond, VA 23298, USA

    2 shared publications
  • Aijun Xu

    Department of Medicine, Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Department of Anesthesiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China; and

    1 shared publication
  • Barrett Kenny

    Department of Medicine, Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia

    1 shared publication
  • Chris Mehfoud

    Department of Medicine, Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia

    1 shared publication
  • Clive M. Baumgarten

    Department of Medicine, Division of Cardiology, Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond, Virginia; Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine, Richmond, Virginia

    1 shared publication

Latest Publications

  • Hypoxia-induced antizyme inhibitors 2 regulates cisplatin resistance through epithelia-mesenchymal transition pathway in non-small cell lung cancer

    by Qin Shi, Qiaolin Chen, Zhan Zhou, Xiuxia Zheng, Xinhui Huang, Minshan Fang, Ying Hu, Li Song, Hualing Yang, Qun Chen


  • Open Access

    Aging‐induced Mitochondrial Damage: The Role of Endoplasmic Reticulum Stress

    by Qun Chen, Jeremy Thompson, Ying Hu, Edward J. Lesnefsky

    Rationale: Mitochondrial (MITO) dysfunction occurs with age in the heart and decreases the tolerance of the aged heart to superimposed cardiac stress. It is unclear how aging leads to MITO dysfunction. The endoplasmic reticulum (ER) is closely connected to MITO via shared membrane domains that mediate ER‐MITO cross‐talk including calcium loading. Induction of ER stress leads to MITO dysfunction in adult hearts. ER stress is increased with aging in the heart. Objective: To study the contribution of ER stress to MITO dysfunction during the progression of cardiac aging. Methods: Subsarcolemmal MITO (SSM) and interfibrillar MITO (IFM) were isolated from 3, 12, 18, and 24 Mon. male C57BL/6 mouse hearts (NIA Colony, Charles River). Oxidative phosphorylation (OXPHOS, nAO/min/mg protein) was measured in isolated MITO. Calcium Retention Capacity (nmol calcium/mg protein) was used to reflect the sensitivity to calcium‐induced mitochondria permeability transition pore opening (MPTP). The contents of CHOP (transcription factor C/EBP homologous protein) and cleaved ATF6 (50 kDa) were used as markers of ER stress. Results: ER stress increased during aging as shown by greater CHOP and cleaved ATF6 contents at 18 Mon. (Figure) whereas OXPHOS remained unchanged (Table). OXPHOS with complex I (glutamate+malate) and complex IV (TMPD+ascorbate) substrates was decreased at 24 Mon. in IFM. OXPHOS in SSM remained unaltered by age (data not shown). Susceptibility to (MPTP) opening was increased at 24 Mon. in IFM. Conclusion: Aging leads to increased ER stress that occurs before the onset of MITO dysfunction. ER‐IFM crosstalk, likely involving altered Ca +2 dynamics as indicated by increased MPTP susceptibility, is a potential new mechanism of age‐induced MITO defects in the heart. Age‐induced defects in IFM, in turn, exacerbate cardiac injury in response to superimposed cardiac disease, including ischemia‐reperfusion. Support or Funding Information This work was supported by the Office of Research and Development, Medical Research Service Merit Review Award (2IO1BX001355‐01A2) and Department of Veterans Affairs (EJL); National Institutes of Health NIH R21AG054975‐01 (QC) This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .


  • Open Access

    Transient complex I inhibition at the onset of reperfusion by extracellular acidification decreases cardiac injury

    by Aijun Xu, Karol Szczepanek, Michael W. Maceyka, Thomas Ross, Elizabeth Bowler, Ying Hu, Barrett Kenny, Chris Mehfoud, Pooja N. Desai, Clive M. Baumgarten, et al.

    A reversible inhibition of mitochondrial respiration by complex I inhibition at the onset of reperfusion decreases injury in buffer-perfused hearts. Administration of acidic reperfusate for a brief period at reperfusion decreases cardiac injury. We asked if acidification treatment decreased cardiac injury during reperfusion by inhibiting complex I. Exposure of isolated mouse heart mitochondria to acidic buffer decreased the complex I substrate-stimulated respiration, whereas respiration with complex II substrates was unaltered. Evidence of the rapid and reversible inhibition of complex I by an acidic environment was obtained at the level of isolated complex, intact mitochondria and in situ mitochondria in digitonin-permeabilized cardiac myocytes. Moreover, ischemia-damaged complex I was also reversibly inhibited by an acidic environment. In the buffer-perfused mouse heart, reperfusion with pH 6.6 buffer for the initial 5 min decreased infarction. Compared with untreated hearts, acidification treatment markedly decreased the mitochondrial generation of reactive oxygen species and improved mitochondrial calcium retention capacity and inner mitochondrial membrane integrity. The decrease in infarct size achieved by acidic reperfusion approximates the reduction obtained by a reversible, partial blockade of complex I at reperfusion. Extracellular acidification decreases cardiac injury during reperfusion in part via the transient and reversible inhibition of complex I, leading to a reduction of oxyradical generation accompanied by a decreased susceptibility to mitochondrial permeability transition during early reperfusion.